A study published in BMC Medicine highlighted the significance of gut microbiota modulation in autoimmune disease management. Probiotics, defined as beneficial microorganisms that colonize the gut and modulate host immunity and metabolism, offer a promising avenue for treatment, particularly for conditions such as ulcerative colitis.